Giuseppe Lucisano
University of Bari
Publications 77
Published on Sep 18, 2019in Journal of Neurology4.20
Damiano Paolicelli24
Estimated H-index: 24
(University of Bari),
Giuseppe Lucisano19
Estimated H-index: 19
+ 30 AuthorsGiovanna De Luca13
Estimated H-index: 13
Background The increase in disease-modifying drugs (DMDs) allows individualization of treatment in relapsing multiple sclerosis (RMS); however, the long-term impact of different treatment sequences is not well established. This is particularly relevant for MS patients who may need to postpone more aggressive DMD strategies.
Published on Jul 1, 2019in International Journal of Infectious Diseases3.54
Antonella Frattari2
Estimated H-index: 2
Vincenzo Savini15
Estimated H-index: 15
+ 9 AuthorsPaolo Fazii9
Estimated H-index: 9
Abstract Background Gram-negative Multi-Drug-Resistant Organisms (GNMDROs) cause an increasing burden of disease in Intensive Care Units (ICUs). We deployed a multifaceted intervention to control selection and transmission of GNMDROs and to estimate at which rate GNMDROs would decline with our interventional bundle. Methods Interventions implemented in 2015: in-ward Antimicrobial-Stewardship-Program for appropriate management of antimicrobial prescription; infection monitoring with nasal/rectal ...
Published on May 1, 2019in Nutrition Metabolism and Cardiovascular Diseases3.34
Maria Chiara Rossi21
Estimated H-index: 21
Antonio Nicolucci54
Estimated H-index: 54
+ 22 AuthorsFrancesco Romeo30
Estimated H-index: 30
Abstract Background and aims Hypoglycemia represents a relevant burden in people with diabetes. Consequences of hypoglycemia/fear of hypoglycemia on quality of life (QoL) and behaviors of patients with T1DM and T2DM were assessed. Methods and results HYPOS-1 was an observational retrospective study. Fear of hypoglycemia (Fear of Hypoglycemia Questionnaire, FHQ), general health status (visual analog scale of EuroQol questionnaire, EQ5D-VAS) psychological well-being (WHO-5 well being index, WHO-5)...
Published on Apr 1, 2019in Diabetes Care15.27
Antonio Ceriello80
Estimated H-index: 80
Maria Chiara Rossi21
Estimated H-index: 21
+ 8 AuthorsG. Russo28
Estimated H-index: 28
(UNIME: University of Messina)
OBJECTIVE An association between variability in clinical parameters (HbA 1c , blood pressure, cholesterol, and uric acid) and risk of complications in type 2 diabetes has been reported. In this analysis, we investigated to what extent such variability is associated with overall quality of care. RESEARCH DESIGN AND METHODS The quality of care summary score (Q-score) represents a validated, overall quality of care indicator ranging between 0 and 40; the higher the score, the better the quality of ...
Published on Mar 5, 2019in JAMA51.27
Stefano Balducci17
Estimated H-index: 17
(Sapienza University of Rome),
Valeria D’Errico4
Estimated H-index: 4
(Sapienza University of Rome)
+ 10 AuthorsSilvano Zanuso2
Estimated H-index: 2
(University of Greenwich)
Importance There is no definitive evidence that changes in physical activity/sedentary behavior can be maintained long term in individuals with type 2 diabetes. Objective To investigate whether a behavioral intervention strategy can produce a sustained increase in physical activity and reduction in sedentary time among individuals with type 2 diabetes. Design, Setting, and Participants The Italian Diabetes and Exercise Study 2 was an open-label, assessor-blinded, randomized clinical superiority ...
Published on Dec 1, 2018in Acta Diabetologica3.00
Basilio Pintaudi13
Estimated H-index: 13
Raffaella Fresa5
Estimated H-index: 5
+ 10 AuthorsGiuseppe Lucisano19
Estimated H-index: 19
Aims To assess the risk of adverse neonatal outcomes in women with gestational diabetes (GDM) by identifying subgroups of women at higher risk to recognize the characteristics most associated with an excess of risk.
Published on Dec 1, 2018in Diabetes Therapy2.83
Paola Ponzani2
Estimated H-index: 2
Cesare Berra2
Estimated H-index: 2
+ 5 AuthorsMaria Chiara Rossi21
Estimated H-index: 21
Introduction Real-world evidence on effectiveness and safety of insulin degludec (IDeg) in patients with diabetes is a priority. The aim of the study was to evaluate patterns of use and the long-term effectiveness and safety of IDeg in routine clinical practice.
Published on Dec 1, 2018in Journal of The American Society of Nephrology8.55
Valeria Saglimbene14
Estimated H-index: 14
Suetonia C. Palmer38
Estimated H-index: 38
(University of Otago)
+ 22 AuthorsFabio Pellegrini50
Estimated H-index: 50
(Biogen Idec)
Background The comparative effectiveness of treatment with angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), or their combination in people with albuminuria and cardiovascular risk factors is unclear. Methods In a multicenter, randomized, open label, blinded end point trial, we evaluated the effectiveness on cardiovascular events of ACE or ARB monotherapy or combination therapy, targeting BP Results Because of slow enrollment, the trial was modified and stoppe...